Abdominal aortic aneurysm (AAA) pathogenesis is characterized by chronic inflammation and matrix metalloproteinase (MMP)-mediated aortic wall destruction. 1 Cytokines induce MMP production within the aortic wall, 2 and large AAAs secrete interleukin (IL) 6 into the circulation. 3, 4 Interleukins stimulate the hepatic transcription of acute-phase reactants, including fibrinogen 5 and C-reactive protein (CRP). 6 Preoperative plasma CRP levels are elevated individuals with a large AAA (Ͼ55 mm). 7 Results from studies that used intra-aortic sampling, however, suggest that the aneurysm sac does not secrete CRP, 4 and endogenous synthesis is evident in only 25% of explanted AAA tissue. 8 Furthermore, epidemiologic studies suggest that CRP levels track aneurysm expansion, 9, 10 providing evidence that elevated CRP levels represent a secondary response to aneurysm expansion.
Inflammation and coagulation are closely entwined, with evidence supporting a bidirectional relationship. 11 Complement cascade activation is a key inflammatory component 12 and strongly associated with coagulation. 13 IL-6 stimulates the expression of tissue factor by macrophages, causing an intravascular prothrombotic stimulus.
14 Plasma markers of fibrin turnover are elevated in large AAAs . 15 We recently showed that this enhanced state of fibrin turnover is present during early AAA development independent of smoking, cardiovascular disease (CVD), and conventional risk factors. 19 Fibrin degradation products include D-dimer, which has multiple proinflammatory effects, including the transcription of cytokines and acutephase reactants. [20] [21] [22] At present, the interaction between inflammation and coagulation remains ill defined during early AAA pathogenesis. We hypothesized that fibrin turnover might contribute to the plasma inflammatory response. The aim of this case-control study was to characterize the plasma inflammatory response in men with a small AAA (range, 30-54 mm) and to determine the effect of plasma D-dimer levels.
METHODS
This hospital based case-control study was approved by the Leeds Teaching Hospitals National Health Service (NHS) Trust Local Research Ethics Committee (Project number CA03/088). All study participants provided informed consent according to the protocol approved by the Leeds NHS Trust Ethics Committee.
Sample size. Inflammatory markers are elevated in individuals with a large AAA. 4, 7, 15, 16 Assuming 50% of these differences are clinically important for a population with a small AAA, then 75 AAA individuals and 90 controls would provide Ն90% power at the 5% significance level (␣ ϭ 0.05) for all inflammatory markers.
Study participants. The study identified 105 white men with a small AAA (range, 30-54 mm) from consecutive referrals to the vascular outpatient department. All were aged Ն65 years to maximize recruitment (AAA prevalence increases with age) and because an AAA is unlikely to develop over time in an individual with an aorta Ͻ30 mm. The study excluded 10 men (9.5%) because of an underlying malignancy, active inflammatory conditions, oral anticoagulant or steroid therapy, or who had undergone recent surgery or had experienced an acute thrombotic event (Ͻ3 months). Of the 95 eligible men, 75 (78.9%) agreed to participate. They were compared with 90 controls who were recruited on a matched-pair basis (age, sex, and race) from consecutive new referrals to vascular, general surgical, and urology outpatient clinics. All controls had an aortic diameter of Ͻ30 mm and were subject to identical exclusion criteria.
Clinical assessment. All participants fasted for 10 hours overnight and were asked to refrain from smoking during this period. A detailed clinical history was taken and the medical notes reviewed. Tobacco smoking, alcohol consumption, drug history, and the presence of atherosclerotic cardiovascular disease, defined as ischemic heart disease, cerebrovascular disease, or peripheral arterial disease, were noted. Blood pressure was determined by automated cuff to the nearest 2 mm Hg and taken as the mean of three readings. Body mass index was calculated as kg/m 2 . The waist/hip ratio was calculated as minimal abdominal girth/ maximal protrusion of the hips (cm) at the symphysis pubis. A 12-lead electrocardiogram was recorded to exclude myocardial ischemia or previous silent infarction. Resting anklebrachial pressure indices (ABPI) were measured in both legs using a hand-held 8-MHz Doppler probe (Handydop SciMed, Bristol, UK).
A 19-gauge needle was used to obtain a sample of free-flowing venous blood (50 mL) from an antecubital vein. The sample was transferred to a lithium heparin tube at room temperature for a plasma lipid profile and the inflammatory marker high-sensitivity (hs) CRP. Lithium fluoride was used for the plasma glucose assay and sodium citrate for all inflammatory markers. For D-dimer, the sodium citrate tube was precooled and transferred immediately onto ice after venesection.
Ultrasound assessment. B-mode abdominal ultrasound imaging (Siemens Sonoline Elegra, Siemens Medical Systems, Issaquah, Wash) was performed by a single observer in the transverse scan plane. Maximal infrarenal anteroposterior (AP max ) aortic diameter, which correlates well with 3-dimensional computed tomography, 23 was taken as the mean of two measurements by electronic calliper. For intrasubject variability, the 95% limits of agreement were Ϯ 2.3 mm.
Laboratory methods. Room temperature sample tubes were centrifuged at 3000g (MSE, Sanyo Gallenkamp PLC, Loughborough, UK) for 20 minutes. Iced samples were centrifuged at 4000g for 30 minutes in a precooled centrifuge (Coolspin, Fisons Scientific, Loughborough, UK) at 4°C. Plasma aliquots were snap frozen in liquid nitrogen before being placed in long-term storage at -40°C. All assays were performed in duplicate, and mean levels were calculated. Plasma fibrinogen was measured on a KC10 coagulometer (Amelung, Germany) using the Clauss method. D-dimer (TintElize, Biopool Intl, Umea, Sweden) and IL-6 (DuoSet, R and D Systems, Minneapolis, Minn) were measured by commercially available enzyme-linked immunosorbent assay (ELISA) hsCRP assay. Complement C3 level was measured by in-house ELISA using antibodies from DAKOcytomation (Glostrup, Denmark). The interassay coefficients of variation for fibrinogen, D-dimer, IL-6, hsCRP, and complement C3 were 3.5%, 5.3%, 2.3%, 5.7%, and 11.0%, respectively.
Statistical methods. Data were assessed for normality using a one-sample Kolmogorov-Smirnov test. Normally distributed data are presented as mean (standard deviation), log-normal data as geometric mean (antilogged 95% confidence intervals), non-normally distributed data as median and interquartile range (IQR; 25th, 75th percentiles) and categoric data as a proportion (%). An independent t test was used to assess for a difference in means, MannWhitney U test for a difference in ranks, and 2 test for difference in proportions between the study groups. For the plasma inflammatory markers (n ϭ 5), to protect against multiple type 1 error, we considered only values of P Յ .05 /n to be significant after the method of Bonferroni.
Bivariable correlation was used to examine the association between inflammatory markers and aortic diameter (AP max ). Pearson correlation coefficients () were calculated if both variables were normally distributed and the Spearman rank coefficient () if one or more variables were nonparametric. Multiple linear regression analysis was used to control for systematic differences between study groups. Inflammatory markers that were elevated in men with AAA were entered into a forward-stepwise regression model as the dependent variable. Case type was added as the first covariate, and inflammatory marker levels were then sequentially adjusted for (1) smoking status, (2) atherosclerotic CVD, (3) conventional risk factors, (4) drug therapies, (5) inflammatory mediators, and (6) D-dimer levels. All analyses were performed using SPSS 12.0 software (SPSS Inc, Chicago, Ill). Statistical significance was taken at the 5% level (␣ ϭ 0.05). Sample size was determined using Power and Precision 3 software (Biostat, Englewood, NJ).
RESULTS
Clinical and biochemical characteristics. The clinical, biochemical, and hemostatic characteristics of the study groups are reported in Table I . The median (IQR) aortic diameter in the AAA group was 41 mm (35, 47 mm) vs 20 mm (18, 22 mm) in controls (P Ͻ .001). Both groups were similar in terms of age, alcohol intake, anthropometric characteristics, systolic blood pressure, triglycerides, and high-density lipoprotein cholesterol levels. The AAA group had a higher prevalence of atherosclerotic CVD, angiotensin-converting enzyme-inhibitor (ACEI) therapy, and antiplatelet therapy. There was significantly higher cumulative cigarette exposure, prevalence of current smokers, those with established diabetes, 2-hour glucose, and HbA 1c (%) levels in AAA participants. Total cholesterol and low-density lipoprotein cholesterol levels were lower in AAA participants, although a higher proportion was taking statins.
Markers of inflammation. Fibrinogen, hsCRP, and D-dimer levels were significantly elevated in the AAA group (Table I) ; however, there was no difference in C3 or IL-6 levels. On bivariable analysis, hsCRP and fibrinogen levels both correlated with aortic diameter (Table II) ; however, the strongest association was with D-dimer. Significant correlation between plasma cytokines (IL-6), acute-phase reactants (hsCRP, fibrinogen), and markers of fibrin degradation (D-dimer) were evident (Table II) .
Multiple linear regression analysis
Fibrinogen model. Multiple linear regression analysis was performed using fibrinogen as the dependent variable and case type (AAA vs control) as the first covariate. Sequential adjustments were made using (1) smoking status and pack-years smoked; (2) atherosclerotic CVD (vs none) and the ABPI; (3) total-cholesterol levels, HbA 1c (%), and impaired glucose regulation or diabetes; (4) statin, antiplatelet, or ACEI therapy (vs none); and (5) (Table III) only D-dimer, C3, and IL-6 independently predicted hsCRP levels (R 2 ϭ 24.2%). D-dimer model. D-dimer levels remained significantly elevated in AAA participants after adjustment for (1) smoking status and pack-years; (2) atherosclerotic CVD and ABPI; (3) total-cholesterol levels, HbA 1c (%), and impaired glucose regulation or diabetes; (4) statin, antiplatelet, or ACEI therapy, and (5) inflammatory mediators (IL-6, C3, hsCRP). In the final model (Table III) . case type, CVD presence, and ACEI therapy independently predicted D-dimer levels (R 2 ϭ 52.3%).
DISCUSSION
AAA are defined by an aortic diameter Ͼ30 mm 24 and effect about 5% of elderly men. 25 Aortic diameter predicts for risk of rupture, which accounts for about 6000 deaths per annum in England and Wales. 26 For a small AAA (30 to 54 mm,) risk of rupture is low (about 1% per annum), and mortality primarily relates to atherosclerotic CVD. 27 The presence of a large AAA (Ն55 mm), however, confers a significant risk of rupture necessitating repair by surgical or endovascular intervention. 25, 28 Notwithstanding repair, CVD risk remains high in these patients. Inflammatory processes are of pivotal importance in AAA pathogenesis 1 and are closely entwined with coagulation.
11 Plasma markers of inflammation 4, 7, 17 and fibrin turnover are elevated in individuals with a large AAA (55 mm). [15] [16] [17] [18] We have recently shown this enhanced systemic state of fibrin turnover occurs during early AAA development and cannot be explained by smoking, atherosclerotic CVD, or conventional risk factors. 19 At present, the inflammatory response remains poorly characterized during the early AAA development; yet, this represents the optimal stage for novel therapeutic interventions to delay sac growth.
This study illustrates that men with small AAA (30 to 54 mm) have significantly increased plasma fibrinogen, hsCRP, and D-dimer levels, supporting the existence of a generalized proinflammatory state. Indeed, significant correlations between fibrinogen, hsCRP, and D-dimer levels were noted. These findings are consistent with previous observations in coronary artery disease, which Lowe et al 29 postulated may be mediated by IL-6. 29 In our study, aortic diameter correlated with fibrinogen, hsCRP, and D-dimer levels as previously documented. 8, 10, 30 The tightest associ-ation was observed for D-dimer, which independently predicted AAA status and may serve as a stronger marker for early aneurysm disease. Isolated studies have measured inflammatory markers in individuals with small AAA. 9, 10 These studies, however, are methodologically limited by (1) lack of a control group, 10 (2) failing to adequately characterize aneurysm diameter, 9 or (3) failing to comprehensively adjust for confounding influences. 9 We minimized bias in this hospital case-control study by synchronously recruiting two wellcharacterized study groups that were matched for age, sex, and race. We concede that an epidemiologic study of cross-sectional or nested case-control design provides more robust evidence. Both would require a sizeable study population and have clear implications on cost and duration that were beyond our financial constraints. Although sys- Inflammatory markers (n ϭ 5) statistical significance taken at P Ͻ .05/n after Bonferroni method.
tematic differences between our study groups were evident, these potentially confounding influences were controlled for by regression analysis. Of particular interest was the difference in prevalence of diabetes across study groups: Firstly, the prevalence of participants with established diabetes was low in controls, which may reflect volunteer bias. The presence of newly diagnosed diabetes or impaired glucose regulation was more common in the control group. Consequently, the overall prevalence of dysglycemia was about 20%, which for this age group is directly comparable to the general population.
Secondly, the prevalence of diabetes was high in the AAA patients. This is at odds with pooled epidemiologic data suggesting that diabetes has a protective effect against AAA development. 31 The mechanisms that underpin this protective effect are currently undetermined. One putative mechanism involves insulin resistance, elevated plasminogen activator inhibitor type 1 levels, and suppressed plasmin-mediated proteolysis. Alternatively, hyperglycemia leads to the formation of advanced glycation end products.
These are known to promote extracellular matrix deposition cross-linking and inhibit MMP activity. Our study was small and hospital-based. Consequently, the high prevalence of diabetic participants in the AAA group likely reflects selection bias. We emphasize, however, that all potential sources of dysglycemic confounding were fully adjusted for in the regression analysis.
Acute-phase reactants. Greatly elevated levels of acutephase response proteins occur during acute infection or inflammation and are mediated by IL-1 or IL-6. 5, 6 Moderate elevations reflect chronic hepatic stimulation, although vascular CRP production is now recognized and may contribute to plasma levels. 32, 33 Despite this, endogenous CRP synthesis is evident in only 25% of AAA explants. 8 Field studies of intraoperative flow that directly sampled aortic blood show large AAAs do appear to secrete CRP. 4 Furthermore, epidemiologic data show that CRP levels track aneurysm development. 9, 10 These studies provide persuasive evidence that elevated CRP levels represent a secondary hepatic response to aneurysm expansion. Elevated hsCRP levels in our AAA population support previous observations in individuals with large AAA. 7 Conversely, Dawson et al 4 failed to demonstrate any differences, but with only 27 AAAs and 15 controls, their study was almost certainly subject to type 2 error. 4 Elevated CRP levels have been described in association with smoking, atherosclerotic disease, and risk factor clustering in the metabolic syndrome. 29, 34 CRP levels are elevated in screendetected AAA after adjustment for atherosclerosis or smoking. 9 Nevertheless, all potential confounders were not included in a single regression model, and AAA morphology was ill defined. We have recruited a well-characterized study population and adjusted for a comprehensive array of confounding influences.
In this study, CRP levels remained significantly elevated in participants with AAA after adjustment for smoking, atherosclerotic CVD, conventional risk factors, and inflammatory mediators (C3 and IL-6). With the addition of D-dimer to the model, however, this association lost significance. The same effect was observed when D-dimer was added to the fibrinogen model. These findings may indicate that fibrin degradation mediates the increased levels of acute-phase reactants in AAA participants, although the cross-sectional nature of this study did not allow us to confirm or refute this hypothesis. D-dimer has multiple proinflammatory effects, including (1) neutrophil and monocyte activation, (2) the stimulation of cytokine release (IL-1 and IL-6), and (3) increased synthesis of hepatic acute-phase reactants. [20] [21] [22] 35 As a consequence, D-dimer has a biologically plausible role in governing the hepatic transcription of acute-phase reactants, although the molecular basis for this remains unclear.
Interleukins. We did not observe any difference in IL-6 levels between study groups. Interleukin-6 has been implicated in AAA pathogenesis, with high levels of messenger RNA and protein present in explanted tissue. 36 Large AAAs have been reported to secrete IL-6 into the circulation, 3, 4 and plasma levels are elevated in these individuals compared with controls. 4, 17 The reports cited, however, measured inflammatory markers in individuals with aneurysms that were larger than those in the population we studied. The IL response may only become significant during the later stages of AAA development, which may explain the discrepancies between previous reports and our findings. Indeed, other studies have found no correlation between levels of IL-6 and AAA size or growth rate in populations with small AAAs, 3 which are in agreement with our findings.
D-dimer. D-dimer levels remained elevated in individuals with small AAAs after adjustment for smoking, CVD, atherosclerotic risk factors, and inflammatory markers. These findings provide unequivocal evidence of enhanced fibrinolytic activity during early AAA development. These observations are consistent with individuals with large AAAs, [15] [16] [17] [18] where markers of fibrin turnover correlate with intraluminal thrombus thickness. 15 Mounting evidence suggests the intraluminal thrombus is biologically active and participates in AAA pathogenesis 37 through the sequestration of inflammatory leukocytes and proteolytic enzymes. 38 The thrombus mass itself continually remodels with thrombin deposition. 39 Conversely, plasmin-mediated fibrinolysis results in MMP activation 38 and the release of degradation products. 18 Continual thrombus remodeling may, therefore, account for increased D-dimer levels seen in our population with small AAA. Future studies should be directed towards intra-aortic sampling to test this hypothesis.
Other factors may influence basal fibrin turnover, however, including the presence of atherosclerosis. 15, 40 In this study we could not fully exclude the presence of subclinical atherosclerosis by questionnaire, electrocardiogram, and ABPI alone. Although subclinical atherosclerosis may confound our observations, fibrin turnover falls after aneurysm repair, 15, 40 which provides further evidence that the aneurysm sac itself drives much of the hemostatic perturbation.
CONCLUSIONS
The presence of elevated CRP and fibrinogen levels support the existence of a proinflammatory state in men with small AAAs. D-dimer levels are most tightly associated with AAA status, however, and fibrin degradation may mediate the observed elevation in acute phase reactants. Further studies are required to investigate this hypothesis and whether novel therapeutic strategies to inhibit fibrin turnover slow early AAA growth.
AUTHOR CONTRIBUTIONS
Conception and design: DS, RA Analysis and interpretation: DP Data collection: HA, LC Writing the article: DP, TR Critical revision of the article: DP Final approval of the article: DP, DS Statistical analysis: DP Obtained funding: DS, RA Overall responsibility: DS
